Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...

From immune cell therapies to measles outbreaks to federal attacks on public health, these are some of the health topics ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

By one calculation, spending on AI accounted for 92 percent of America’s GDP growth in the first half of 2025. This year, a ...

As more people turn to donor sperm to grow their families, a new sperm bank is challenging outdated norms.

Immense progress in gene editing, drug discovery and conservation are just some of the reasons to be cheerful about 2025 ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled “Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD” has been ...